nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ALB—hepatitis B	0.651	1	CbGaD
Gliclazide—Laboratory test abnormal—Entecavir—hepatitis B	0.00854	0.034	CcSEcCtD
Gliclazide—Hepatomegaly—Entecavir—hepatitis B	0.00504	0.0201	CcSEcCtD
Gliclazide—Glycosuria—Entecavir—hepatitis B	0.0044	0.0175	CcSEcCtD
Gliclazide—VEGFA—NOTCH1 regulation of human endothelial cell calcification—ALPL—hepatitis B	0.00437	0.0446	CbGpPWpGaD
Gliclazide—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0043	0.0171	CcSEcCtD
Gliclazide—Hepatomegaly—Telbivudine—hepatitis B	0.00414	0.0165	CcSEcCtD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—hepatitis B	0.00407	0.0416	CbGpPWpGaD
Gliclazide—Fungal skin infection—Lamivudine—hepatitis B	0.00395	0.0157	CcSEcCtD
Gliclazide—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00363	0.0145	CcSEcCtD
Gliclazide—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00289	0.0115	CcSEcCtD
Gliclazide—Hepatic failure—Entecavir—hepatitis B	0.00288	0.0115	CcSEcCtD
Gliclazide—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00288	0.0115	CcSEcCtD
Gliclazide—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00281	0.0112	CcSEcCtD
Gliclazide—ALB—Scavenging of heme from plasma—HP—hepatitis B	0.00269	0.0275	CbGpPWpGaD
Gliclazide—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00265	0.0106	CcSEcCtD
Gliclazide—Respiratory tract infection—Lamivudine—hepatitis B	0.00263	0.0105	CcSEcCtD
Gliclazide—Blood triglycerides increased—Lamivudine—hepatitis B	0.00252	0.01	CcSEcCtD
Gliclazide—ABCC8—Potassium Channels—KCNH1—hepatitis B	0.00235	0.0241	CbGpPWpGaD
Gliclazide—Hepatomegaly—Lamivudine—hepatitis B	0.00233	0.00929	CcSEcCtD
Gliclazide—KCNJ11—Potassium Channels—KCNH1—hepatitis B	0.00228	0.0233	CbGpPWpGaD
Gliclazide—Renal impairment—Telbivudine—hepatitis B	0.00224	0.0089	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IFNGR1—hepatitis B	0.00223	0.0228	CbGpPWpGaD
Gliclazide—VEGFA—Hypertrophy Model—IL18—hepatitis B	0.0022	0.0225	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—HLA-DPA1—hepatitis B	0.00216	0.0221	CbGpPWpGaD
Gliclazide—Pain in extremity—Telbivudine—hepatitis B	0.00213	0.00847	CcSEcCtD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.00211	0.0216	CbGpPWpGaD
Gliclazide—Upper respiratory tract infection—Entecavir—hepatitis B	0.00208	0.00828	CcSEcCtD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.00204	0.0209	CbGpPWpGaD
Gliclazide—Hyperglycaemia—Entecavir—hepatitis B	0.00202	0.00804	CcSEcCtD
Gliclazide—Blood disorder—Lamivudine—hepatitis B	0.00198	0.00788	CcSEcCtD
Gliclazide—Renal failure—Entecavir—hepatitis B	0.00196	0.00781	CcSEcCtD
Gliclazide—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00191	0.00762	CcSEcCtD
Gliclazide—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0019	0.00756	CcSEcCtD
Gliclazide—Hepatobiliary disease—Entecavir—hepatitis B	0.00189	0.00752	CcSEcCtD
Gliclazide—Gastritis—Telbivudine—hepatitis B	0.00188	0.0075	CcSEcCtD
Gliclazide—Abdominal distension—Telbivudine—hepatitis B	0.00185	0.00737	CcSEcCtD
Gliclazide—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00184	0.00733	CcSEcCtD
Gliclazide—Viral infection—Lamivudine—hepatitis B	0.00183	0.00728	CcSEcCtD
Gliclazide—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00183	0.00728	CcSEcCtD
Gliclazide—Hepatitis—Entecavir—hepatitis B	0.00179	0.00714	CcSEcCtD
Gliclazide—Oedema peripheral—Entecavir—hepatitis B	0.00176	0.00703	CcSEcCtD
Gliclazide—Abdominal discomfort—Telbivudine—hepatitis B	0.00176	0.00702	CcSEcCtD
Gliclazide—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00175	0.00696	CcSEcCtD
Gliclazide—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00175	0.00695	CcSEcCtD
Gliclazide—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00174	0.0178	CbGpPWpGaD
Gliclazide—Hearing impaired—Lamivudine—hepatitis B	0.00173	0.00691	CcSEcCtD
Gliclazide—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00173	0.00691	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00171	0.00681	CcSEcCtD
Gliclazide—Renal failure—Telbivudine—hepatitis B	0.00161	0.00642	CcSEcCtD
Gliclazide—Neuropathy peripheral—Telbivudine—hepatitis B	0.00161	0.0064	CcSEcCtD
Gliclazide—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00159	0.0162	CbGpPWpGaD
Gliclazide—Mental disorder—Entecavir—hepatitis B	0.00157	0.00625	CcSEcCtD
Gliclazide—Malnutrition—Entecavir—hepatitis B	0.00156	0.00621	CcSEcCtD
Gliclazide—Neuropathy—Lamivudine—hepatitis B	0.00155	0.00618	CcSEcCtD
Gliclazide—Hepatobiliary disease—Telbivudine—hepatitis B	0.00155	0.00618	CcSEcCtD
Gliclazide—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00152	0.00606	CcSEcCtD
Gliclazide—VEGFA—Endochondral Ossification—ALPL—hepatitis B	0.00151	0.0155	CbGpPWpGaD
Gliclazide—Flatulence—Adefovir Dipivoxil—hepatitis B	0.0015	0.00597	CcSEcCtD
Gliclazide—Urine output increased—Lamivudine—hepatitis B	0.00149	0.00595	CcSEcCtD
Gliclazide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00147	0.00586	CcSEcCtD
Gliclazide—Hepatitis—Telbivudine—hepatitis B	0.00147	0.00586	CcSEcCtD
Gliclazide—Hypoaesthesia—Telbivudine—hepatitis B	0.00146	0.00583	CcSEcCtD
Gliclazide—Pharyngitis—Telbivudine—hepatitis B	0.00146	0.00582	CcSEcCtD
Gliclazide—VEGFA—Alpha9 beta1 integrin signaling events—NOS2—hepatitis B	0.00141	0.0144	CbGpPWpGaD
Gliclazide—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00141	0.0056	CcSEcCtD
Gliclazide—Leukopenia—Entecavir—hepatitis B	0.0014	0.00556	CcSEcCtD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00139	0.0142	CbGpPWpGaD
Gliclazide—Sleep disorder—Lamivudine—hepatitis B	0.00138	0.00552	CcSEcCtD
Gliclazide—Polyuria—Lamivudine—hepatitis B	0.00137	0.00544	CcSEcCtD
Gliclazide—Gastroenteritis—Lamivudine—hepatitis B	0.00135	0.00539	CcSEcCtD
Gliclazide—Deafness—Lamivudine—hepatitis B	0.00134	0.00534	CcSEcCtD
Gliclazide—Cough—Adefovir Dipivoxil—hepatitis B	0.00133	0.00529	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00132	0.00525	CcSEcCtD
Gliclazide—Injury—Lamivudine—hepatitis B	0.0013	0.00519	CcSEcCtD
Gliclazide—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0013	0.00516	CcSEcCtD
Gliclazide—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0013	0.00516	CcSEcCtD
Gliclazide—VEGFA—Hypertrophy Model—IFNG—hepatitis B	0.00129	0.0132	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00129	0.00512	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00129	0.0131	CbGpPWpGaD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.00128	0.0131	CbGpPWpGaD
Gliclazide—Malnutrition—Telbivudine—hepatitis B	0.00128	0.0051	CcSEcCtD
Gliclazide—Infection—Entecavir—hepatitis B	0.00126	0.00504	CcSEcCtD
Gliclazide—Renal impairment—Lamivudine—hepatitis B	0.00126	0.00502	CcSEcCtD
Gliclazide—Thirst—Lamivudine—hepatitis B	0.00126	0.00502	CcSEcCtD
Gliclazide—Nervous system disorder—Entecavir—hepatitis B	0.00125	0.00497	CcSEcCtD
Gliclazide—Back pain—Telbivudine—hepatitis B	0.00124	0.00494	CcSEcCtD
Gliclazide—Skin disorder—Entecavir—hepatitis B	0.00124	0.00492	CcSEcCtD
Gliclazide—Hypoglycaemia—Lamivudine—hepatitis B	0.00123	0.00489	CcSEcCtD
Gliclazide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00122	0.00485	CcSEcCtD
Gliclazide—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00122	0.00484	CcSEcCtD
Gliclazide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00121	0.0048	CcSEcCtD
Gliclazide—Ill-defined disorder—Telbivudine—hepatitis B	0.00119	0.00473	CcSEcCtD
Gliclazide—Malaise—Telbivudine—hepatitis B	0.00116	0.0046	CcSEcCtD
Gliclazide—Insomnia—Entecavir—hepatitis B	0.00115	0.00458	CcSEcCtD
Gliclazide—Somnolence—Entecavir—hepatitis B	0.00113	0.00451	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00113	0.00451	CcSEcCtD
Gliclazide—Dyspepsia—Entecavir—hepatitis B	0.00112	0.00446	CcSEcCtD
Gliclazide—Cough—Telbivudine—hepatitis B	0.00112	0.00445	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Entecavir—hepatitis B	0.0011	0.00438	CcSEcCtD
Gliclazide—Fatigue—Entecavir—hepatitis B	0.0011	0.00437	CcSEcCtD
Gliclazide—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00109	0.00435	CcSEcCtD
Gliclazide—Arthralgia—Telbivudine—hepatitis B	0.00109	0.00434	CcSEcCtD
Gliclazide—Chest pain—Telbivudine—hepatitis B	0.00109	0.00434	CcSEcCtD
Gliclazide—Myalgia—Telbivudine—hepatitis B	0.00109	0.00434	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00108	0.00431	CcSEcCtD
Gliclazide—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00108	0.011	CbGpPWpGaD
Gliclazide—Discomfort—Telbivudine—hepatitis B	0.00108	0.00429	CcSEcCtD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—hepatitis B	0.00107	0.011	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00107	0.00427	CcSEcCtD
Gliclazide—Abdominal distension—Lamivudine—hepatitis B	0.00104	0.00415	CcSEcCtD
Gliclazide—Gastrointestinal pain—Entecavir—hepatitis B	0.00104	0.00415	CcSEcCtD
Gliclazide—VEGFA—Platelet degranulation—HSPA5—hepatitis B	0.00104	0.0106	CbGpPWpGaD
Gliclazide—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00104	0.0106	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—KCNH1—hepatitis B	0.00103	0.0105	CbGpPWpGaD
Gliclazide—Nervous system disorder—Telbivudine—hepatitis B	0.00103	0.00408	CcSEcCtD
Gliclazide—Thrombocytopenia—Telbivudine—hepatitis B	0.00102	0.00408	CcSEcCtD
Gliclazide—Skin disorder—Telbivudine—hepatitis B	0.00102	0.00404	CcSEcCtD
Gliclazide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00102	0.00404	CcSEcCtD
Gliclazide—Body temperature increased—Entecavir—hepatitis B	0.00101	0.00401	CcSEcCtD
Gliclazide—Abdominal pain—Entecavir—hepatitis B	0.00101	0.00401	CcSEcCtD
Gliclazide—Bronchitis—Lamivudine—hepatitis B	0.000996	0.00397	CcSEcCtD
Gliclazide—KCNJ11—Neuronal System—KCNH1—hepatitis B	0.000996	0.0102	CbGpPWpGaD
Gliclazide—Abdominal discomfort—Lamivudine—hepatitis B	0.000993	0.00396	CcSEcCtD
Gliclazide—VEGFA—Beta1 integrin cell surface interactions—CD14—hepatitis B	0.000992	0.0101	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—HLA-DPB1—hepatitis B	0.000991	0.0101	CbGpPWpGaD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000991	0.0101	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.00099	0.0101	CbGpPWpGaD
Gliclazide—Pancytopenia—Lamivudine—hepatitis B	0.000984	0.00392	CcSEcCtD
Gliclazide—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000983	0.01	CbGpPWpGaD
Gliclazide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000982	0.00391	CcSEcCtD
Gliclazide—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000982	0.00391	CcSEcCtD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000961	0.00983	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000953	0.00379	CcSEcCtD
Gliclazide—Insomnia—Telbivudine—hepatitis B	0.000946	0.00377	CcSEcCtD
Gliclazide—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000945	0.00967	CbGpPWpGaD
Gliclazide—Paraesthesia—Telbivudine—hepatitis B	0.000939	0.00374	CcSEcCtD
Gliclazide—Hyperglycaemia—Lamivudine—hepatitis B	0.000935	0.00372	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—CDKN2A—hepatitis B	0.000931	0.00952	CbGpPWpGaD
Gliclazide—Depression—Lamivudine—hepatitis B	0.000921	0.00367	CcSEcCtD
Gliclazide—Dyspepsia—Telbivudine—hepatitis B	0.00092	0.00367	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000916	0.00365	CcSEcCtD
Gliclazide—Asthenia—Entecavir—hepatitis B	0.000913	0.00364	CcSEcCtD
Gliclazide—Renal failure—Lamivudine—hepatitis B	0.000908	0.00362	CcSEcCtD
Gliclazide—Neuropathy peripheral—Lamivudine—hepatitis B	0.000906	0.00361	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000903	0.0036	CcSEcCtD
Gliclazide—Fatigue—Telbivudine—hepatitis B	0.000901	0.00359	CcSEcCtD
Gliclazide—Jaundice—Lamivudine—hepatitis B	0.000901	0.00359	CcSEcCtD
Gliclazide—Pain—Telbivudine—hepatitis B	0.000894	0.00356	CcSEcCtD
Gliclazide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000891	0.00355	CcSEcCtD
Gliclazide—Sweating—Lamivudine—hepatitis B	0.000886	0.00353	CcSEcCtD
Gliclazide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000879	0.0035	CcSEcCtD
Gliclazide—Hepatobiliary disease—Lamivudine—hepatitis B	0.000874	0.00348	CcSEcCtD
Gliclazide—Epistaxis—Lamivudine—hepatitis B	0.000871	0.00347	CcSEcCtD
Gliclazide—Diarrhoea—Entecavir—hepatitis B	0.000871	0.00347	CcSEcCtD
Gliclazide—Sinusitis—Lamivudine—hepatitis B	0.000867	0.00345	CcSEcCtD
Gliclazide—Agranulocytosis—Lamivudine—hepatitis B	0.000862	0.00343	CcSEcCtD
Gliclazide—Feeling abnormal—Telbivudine—hepatitis B	0.000862	0.00343	CcSEcCtD
Gliclazide—Gastrointestinal pain—Telbivudine—hepatitis B	0.000855	0.00341	CcSEcCtD
Gliclazide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00085	0.00338	CcSEcCtD
Gliclazide—Dizziness—Entecavir—hepatitis B	0.000842	0.00335	CcSEcCtD
Gliclazide—Rhinitis—Lamivudine—hepatitis B	0.000831	0.00331	CcSEcCtD
Gliclazide—Hepatitis—Lamivudine—hepatitis B	0.000829	0.0033	CcSEcCtD
Gliclazide—Body temperature increased—Telbivudine—hepatitis B	0.000827	0.00329	CcSEcCtD
Gliclazide—Abdominal pain—Telbivudine—hepatitis B	0.000827	0.00329	CcSEcCtD
Gliclazide—Hypoaesthesia—Lamivudine—hepatitis B	0.000825	0.00329	CcSEcCtD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.000823	0.00841	CbGpPWpGaD
Gliclazide—Pharyngitis—Lamivudine—hepatitis B	0.000823	0.00328	CcSEcCtD
Gliclazide—KCNJ11—Type II diabetes mellitus—TNF—hepatitis B	0.000821	0.00839	CbGpPWpGaD
Gliclazide—Vomiting—Entecavir—hepatitis B	0.000809	0.00322	CcSEcCtD
Gliclazide—Rash—Entecavir—hepatitis B	0.000802	0.0032	CcSEcCtD
Gliclazide—Dermatitis—Entecavir—hepatitis B	0.000802	0.00319	CcSEcCtD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.000798	0.00816	CbGpPWpGaD
Gliclazide—Headache—Entecavir—hepatitis B	0.000797	0.00318	CcSEcCtD
Gliclazide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00079	0.00314	CcSEcCtD
Gliclazide—Erythema multiforme—Lamivudine—hepatitis B	0.000784	0.00312	CcSEcCtD
Gliclazide—Rash—Adefovir Dipivoxil—hepatitis B	0.000783	0.00312	CcSEcCtD
Gliclazide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000782	0.00312	CcSEcCtD
Gliclazide—Headache—Adefovir Dipivoxil—hepatitis B	0.000778	0.0031	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—CDKN1A—hepatitis B	0.000761	0.00778	CbGpPWpGaD
Gliclazide—Nausea—Entecavir—hepatitis B	0.000756	0.00301	CcSEcCtD
Gliclazide—Asthenia—Telbivudine—hepatitis B	0.00075	0.00299	CcSEcCtD
Gliclazide—Chills—Lamivudine—hepatitis B	0.000744	0.00296	CcSEcCtD
Gliclazide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00074	0.00757	CbGpPWpGaD
Gliclazide—Pruritus—Telbivudine—hepatitis B	0.00074	0.00295	CcSEcCtD
Gliclazide—Nausea—Adefovir Dipivoxil—hepatitis B	0.000738	0.00294	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IL10—hepatitis B	0.000731	0.00747	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CD40LG—hepatitis B	0.000731	0.00747	CbGpPWpGaD
Gliclazide—VEGFA—Glypican 1 network—TGFB1—hepatitis B	0.000725	0.00741	CbGpPWpGaD
Gliclazide—Malnutrition—Lamivudine—hepatitis B	0.000722	0.00288	CcSEcCtD
Gliclazide—Erythema—Lamivudine—hepatitis B	0.000722	0.00288	CcSEcCtD
Gliclazide—Diarrhoea—Telbivudine—hepatitis B	0.000715	0.00285	CcSEcCtD
Gliclazide—Flatulence—Lamivudine—hepatitis B	0.000711	0.00283	CcSEcCtD
Gliclazide—Tension—Lamivudine—hepatitis B	0.000708	0.00282	CcSEcCtD
Gliclazide—Nervousness—Lamivudine—hepatitis B	0.000701	0.00279	CcSEcCtD
Gliclazide—Back pain—Lamivudine—hepatitis B	0.000698	0.00278	CcSEcCtD
Gliclazide—Dizziness—Telbivudine—hepatitis B	0.000691	0.00275	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—HBE1—hepatitis B	0.000686	0.00701	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.00068	0.00695	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—FASLG—hepatitis B	0.000679	0.00694	CbGpPWpGaD
Gliclazide—Tremor—Lamivudine—hepatitis B	0.000676	0.00269	CcSEcCtD
Gliclazide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000675	0.0069	CbGpPWpGaD
Gliclazide—Ill-defined disorder—Lamivudine—hepatitis B	0.00067	0.00267	CcSEcCtD
Gliclazide—Anaemia—Lamivudine—hepatitis B	0.000667	0.00266	CcSEcCtD
Gliclazide—Vomiting—Telbivudine—hepatitis B	0.000665	0.00265	CcSEcCtD
Gliclazide—Angioedema—Lamivudine—hepatitis B	0.00066	0.00263	CcSEcCtD
Gliclazide—Rash—Telbivudine—hepatitis B	0.000659	0.00263	CcSEcCtD
Gliclazide—Dermatitis—Telbivudine—hepatitis B	0.000659	0.00262	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—FAS—hepatitis B	0.000655	0.0067	CbGpPWpGaD
Gliclazide—Headache—Telbivudine—hepatitis B	0.000655	0.00261	CcSEcCtD
Gliclazide—Malaise—Lamivudine—hepatitis B	0.000651	0.00259	CcSEcCtD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000647	0.00661	CbGpPWpGaD
Gliclazide—Leukopenia—Lamivudine—hepatitis B	0.000646	0.00257	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—HLA-A—hepatitis B	0.000644	0.00658	CbGpPWpGaD
Gliclazide—Loss of consciousness—Lamivudine—hepatitis B	0.000635	0.00253	CcSEcCtD
Gliclazide—Cough—Lamivudine—hepatitis B	0.00063	0.00251	CcSEcCtD
Gliclazide—Convulsion—Lamivudine—hepatitis B	0.000626	0.00249	CcSEcCtD
Gliclazide—Nausea—Telbivudine—hepatitis B	0.000621	0.00247	CcSEcCtD
Gliclazide—Arthralgia—Lamivudine—hepatitis B	0.000615	0.00245	CcSEcCtD
Gliclazide—Myalgia—Lamivudine—hepatitis B	0.000615	0.00245	CcSEcCtD
Gliclazide—Chest pain—Lamivudine—hepatitis B	0.000615	0.00245	CcSEcCtD
Gliclazide—Anxiety—Lamivudine—hepatitis B	0.000613	0.00244	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00061	0.00243	CcSEcCtD
Gliclazide—Discomfort—Lamivudine—hepatitis B	0.000607	0.00242	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—GGT2—hepatitis B	0.000606	0.00619	CbGpPWpGaD
Gliclazide—Dry mouth—Lamivudine—hepatitis B	0.000601	0.00239	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000595	0.00608	CbGpPWpGaD
Gliclazide—Confusional state—Lamivudine—hepatitis B	0.000594	0.00237	CcSEcCtD
Gliclazide—VEGFA—Heart Development—CTNNB1—hepatitis B	0.000589	0.00602	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—HLA-DRB1—hepatitis B	0.000588	0.00601	CbGpPWpGaD
Gliclazide—Infection—Lamivudine—hepatitis B	0.000585	0.00233	CcSEcCtD
Gliclazide—Nervous system disorder—Lamivudine—hepatitis B	0.000578	0.0023	CcSEcCtD
Gliclazide—Thrombocytopenia—Lamivudine—hepatitis B	0.000577	0.0023	CcSEcCtD
Gliclazide—Skin disorder—Lamivudine—hepatitis B	0.000572	0.00228	CcSEcCtD
Gliclazide—Hyperhidrosis—Lamivudine—hepatitis B	0.00057	0.00227	CcSEcCtD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000555	0.00567	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000551	0.00563	CbGpPWpGaD
Gliclazide—Hypotension—Lamivudine—hepatitis B	0.000551	0.00219	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IFNG—hepatitis B	0.00055	0.00562	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000537	0.00214	CcSEcCtD
Gliclazide—Insomnia—Lamivudine—hepatitis B	0.000533	0.00212	CcSEcCtD
Gliclazide—Paraesthesia—Lamivudine—hepatitis B	0.000529	0.00211	CcSEcCtD
Gliclazide—Dyspnoea—Lamivudine—hepatitis B	0.000525	0.00209	CcSEcCtD
Gliclazide—Somnolence—Lamivudine—hepatitis B	0.000524	0.00209	CcSEcCtD
Gliclazide—Dyspepsia—Lamivudine—hepatitis B	0.000519	0.00207	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—TP53—hepatitis B	0.000518	0.0053	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000509	0.00203	CcSEcCtD
Gliclazide—Fatigue—Lamivudine—hepatitis B	0.000508	0.00202	CcSEcCtD
Gliclazide—Pain—Lamivudine—hepatitis B	0.000504	0.00201	CcSEcCtD
Gliclazide—Constipation—Lamivudine—hepatitis B	0.000504	0.00201	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IL2—hepatitis B	0.000489	0.005	CbGpPWpGaD
Gliclazide—Feeling abnormal—Lamivudine—hepatitis B	0.000486	0.00193	CcSEcCtD
Gliclazide—Gastrointestinal pain—Lamivudine—hepatitis B	0.000482	0.00192	CcSEcCtD
Gliclazide—Urticaria—Lamivudine—hepatitis B	0.000468	0.00186	CcSEcCtD
Gliclazide—VEGFA—Platelet degranulation—ALB—hepatitis B	0.000466	0.00477	CbGpPWpGaD
Gliclazide—Abdominal pain—Lamivudine—hepatitis B	0.000466	0.00186	CcSEcCtD
Gliclazide—Body temperature increased—Lamivudine—hepatitis B	0.000466	0.00186	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000461	0.00471	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000448	0.00458	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—ALB—hepatitis B	0.000444	0.00454	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—TGFB1—hepatitis B	0.000444	0.00454	CbGpPWpGaD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000442	0.00452	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—IL6—hepatitis B	0.000441	0.0045	CbGpPWpGaD
Gliclazide—Hypersensitivity—Lamivudine—hepatitis B	0.000434	0.00173	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IFNG—hepatitis B	0.00043	0.00439	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000429	0.00438	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000424	0.00433	CbGpPWpGaD
Gliclazide—Asthenia—Lamivudine—hepatitis B	0.000423	0.00168	CcSEcCtD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—NFKB1—hepatitis B	0.000418	0.00427	CbGpPWpGaD
Gliclazide—Pruritus—Lamivudine—hepatitis B	0.000417	0.00166	CcSEcCtD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—hepatitis B	0.000416	0.00425	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000408	0.00417	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000404	0.00413	CbGpPWpGaD
Gliclazide—Diarrhoea—Lamivudine—hepatitis B	0.000403	0.00161	CcSEcCtD
Gliclazide—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000403	0.00412	CbGpPWpGaD
Gliclazide—Dizziness—Lamivudine—hepatitis B	0.00039	0.00155	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IL2—hepatitis B	0.000382	0.0039	CbGpPWpGaD
Gliclazide—Vomiting—Lamivudine—hepatitis B	0.000375	0.00149	CcSEcCtD
Gliclazide—Rash—Lamivudine—hepatitis B	0.000372	0.00148	CcSEcCtD
Gliclazide—Dermatitis—Lamivudine—hepatitis B	0.000371	0.00148	CcSEcCtD
Gliclazide—Headache—Lamivudine—hepatitis B	0.000369	0.00147	CcSEcCtD
Gliclazide—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000369	0.00377	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—HSPA5—hepatitis B	0.000367	0.00375	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000363	0.00371	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IFNB1—hepatitis B	0.000361	0.00369	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—TGFB1—hepatitis B	0.000352	0.0036	CbGpPWpGaD
Gliclazide—Nausea—Lamivudine—hepatitis B	0.00035	0.00139	CcSEcCtD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000349	0.00357	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000335	0.00343	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—IL6—hepatitis B	0.000334	0.00342	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000331	0.00338	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000327	0.00335	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000323	0.0033	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.00032	0.00327	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000318	0.00325	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000298	0.00305	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TGFB1—hepatitis B	0.000298	0.00304	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—TGFB1—hepatitis B	0.000295	0.00301	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.00029	0.00297	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—hepatitis B	0.000289	0.00296	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IL6—hepatitis B	0.000287	0.00294	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—hepatitis B	0.000287	0.00293	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.000287	0.00293	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000284	0.0029	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	0.000281	0.00287	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HNF4A—hepatitis B	0.000278	0.00285	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TNF—hepatitis B	0.000278	0.00284	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—CTNNB1—hepatitis B	0.000273	0.00279	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000253	0.00258	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—F2—hepatitis B	0.000249	0.00255	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HBE1—hepatitis B	0.000242	0.00247	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HSPA5—hepatitis B	0.000238	0.00243	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—F2—hepatitis B	0.000231	0.00236	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.00022	0.00224	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000215	0.0022	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IFNB1—hepatitis B	0.000214	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000214	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000214	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000213	0.00218	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IFNA1—hepatitis B	0.000209	0.00214	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000207	0.00212	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—ALB—hepatitis B	0.000207	0.00211	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKR1B1—hepatitis B	0.000196	0.002	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IFNA2—hepatitis B	0.000195	0.00199	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000193	0.00197	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKR1B1—hepatitis B	0.00019	0.00194	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GGT2—hepatitis B	0.000188	0.00192	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—F2—hepatitis B	0.000184	0.00188	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CTNNB1—hepatitis B	0.000183	0.00187	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GGT2—hepatitis B	0.000182	0.00186	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000182	0.00186	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	0.000179	0.00183	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—PTEN—hepatitis B	0.000178	0.00182	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000178	0.00182	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000177	0.00181	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000176	0.0018	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000176	0.0018	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000176	0.0018	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IFNG—hepatitis B	0.000175	0.00179	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2A—hepatitis B	0.000168	0.00172	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2—hepatitis B	0.000168	0.00171	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—hepatitis B	0.000166	0.0017	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RIT2—hepatitis B	0.000166	0.00169	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SAG—hepatitis B	0.000166	0.00169	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000163	0.00166	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000161	0.00165	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL2—hepatitis B	0.000156	0.00159	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000151	0.00154	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000147	0.0015	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000146	0.00149	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—NFKB1—hepatitis B	0.000146	0.00149	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000142	0.00145	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	0.000139	0.00142	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	0.000139	0.00142	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000137	0.0014	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000137	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN1A—hepatitis B	0.000137	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—NFKB1—hepatitis B	0.000136	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	0.000131	0.00134	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—hepatitis B	0.00013	0.00133	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—F2—hepatitis B	0.000128	0.00131	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000127	0.0013	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS2—hepatitis B	0.000127	0.0013	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000121	0.00124	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000116	0.00119	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000116	0.00118	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP2A6—hepatitis B	0.000114	0.00116	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—hepatitis B	0.000113	0.00116	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	0.000112	0.00115	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP2A6—hepatitis B	0.00011	0.00113	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ALB—hepatitis B	0.000107	0.00109	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—TGFB1—hepatitis B	0.000104	0.00106	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GOT2—hepatitis B	0.000103	0.00105	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ALB—hepatitis B	0.000101	0.00103	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—hepatitis B	9.99e-05	0.00102	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GOT2—hepatitis B	9.99e-05	0.00102	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	9.91e-05	0.00101	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—hepatitis B	9.34e-05	0.000955	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—hepatitis B	9.15e-05	0.000935	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—hepatitis B	9e-05	0.00092	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GOT1—hepatitis B	8.89e-05	0.000909	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GGT1—hepatitis B	8.89e-05	0.000909	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	8.79e-05	0.000898	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—hepatitis B	8.64e-05	0.000884	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GGT1—hepatitis B	8.62e-05	0.000881	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GOT1—hepatitis B	8.62e-05	0.000881	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—hepatitis B	8.55e-05	0.000874	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CTNNB1—hepatitis B	8.51e-05	0.000869	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HSPA5—hepatitis B	8.38e-05	0.000857	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NFKB1—hepatitis B	8.25e-05	0.000843	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IFNB1—hepatitis B	7.56e-05	0.000773	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IFNA1—hepatitis B	7.38e-05	0.000754	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—hepatitis B	7.27e-05	0.000743	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—hepatitis B	7.26e-05	0.000742	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—hepatitis B	6.87e-05	0.000703	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IFNA2—hepatitis B	6.87e-05	0.000702	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—hepatitis B	6.74e-05	0.000689	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL10—hepatitis B	6.54e-05	0.000668	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.44e-05	0.000658	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—hepatitis B	6.42e-05	0.000656	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKR1B1—hepatitis B	6.32e-05	0.000646	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGT2—hepatitis B	6.06e-05	0.00062	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	5.92e-05	0.000605	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.78e-05	0.000591	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKR1B1—hepatitis B	5.68e-05	0.00058	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—hepatitis B	5.55e-05	0.000567	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGT2—hepatitis B	5.44e-05	0.000556	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.27e-05	0.000539	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—hepatitis B	5.18e-05	0.000529	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKR1B1—hepatitis B	5.18e-05	0.000529	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—hepatitis B	5.07e-05	0.000518	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGT2—hepatitis B	4.96e-05	0.000507	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—hepatitis B	4.73e-05	0.000484	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	4.62e-05	0.000472	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—hepatitis B	4.59e-05	0.000469	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—F2—hepatitis B	4.53e-05	0.000463	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—hepatitis B	4.48e-05	0.000458	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—F2—hepatitis B	4.35e-05	0.000445	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2A6—hepatitis B	3.67e-05	0.000375	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTEN—hepatitis B	3.61e-05	0.000369	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTEN—hepatitis B	3.5e-05	0.000358	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT2—hepatitis B	3.32e-05	0.00034	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2A6—hepatitis B	3.3e-05	0.000337	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.07e-05	0.000314	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—hepatitis B	3.05e-05	0.000312	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2A6—hepatitis B	3.01e-05	0.000307	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT2—hepatitis B	2.98e-05	0.000305	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—hepatitis B	2.93e-05	0.0003	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GOT1—hepatitis B	2.87e-05	0.000293	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GGT1—hepatitis B	2.87e-05	0.000293	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CTNNB1—hepatitis B	2.83e-05	0.000289	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.8e-05	0.000287	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN1A—hepatitis B	2.76e-05	0.000282	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTEN—hepatitis B	2.76e-05	0.000282	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFKB1—hepatitis B	2.74e-05	0.00028	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT2—hepatitis B	2.72e-05	0.000278	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.61e-05	0.000267	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GOT1—hepatitis B	2.57e-05	0.000263	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GGT1—hepatitis B	2.57e-05	0.000263	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—hepatitis B	2.38e-05	0.000243	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GOT1—hepatitis B	2.35e-05	0.00024	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GGT1—hepatitis B	2.35e-05	0.00024	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.35e-05	0.00024	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—hepatitis B	2.29e-05	0.000234	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.14e-05	0.000219	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—hepatitis B	1.96e-05	0.0002	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—hepatitis B	1.88e-05	0.000192	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—hepatitis B	1.72e-05	0.000176	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—hepatitis B	1.37e-05	0.00014	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—hepatitis B	1.25e-05	0.000128	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTEN—hepatitis B	1.16e-05	0.000119	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTEN—hepatitis B	1.04e-05	0.000107	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTEN—hepatitis B	9.52e-06	9.74e-05	CbGpPWpGaD
